These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1171 related articles for article (PubMed ID: 8446359)

  • 1. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
    Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
    Kroll S; Char DH; Quivey J; Castro J
    Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncologic and functional results of 57 malignant melanoma of the uvea treated by curietherapy].
    Bacin F; Albuisson E; Rozan R; Donnarieix D; Verrelle P; Dalens H
    J Fr Ophtalmol; 1991; 14(6-7):383-96. PubMed ID: 1779110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
    Braun UC; Rummelt VC; Naumann GO
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.